Welcome to CDC stacks | Impact of Adjuvant Chemotherapy on Long-Term Employment of Early-Stage Breast Cancer Survivors - 29986 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Impact of Adjuvant Chemotherapy on Long-Term Employment of Early-Stage Breast Cancer Survivors
Filetype[PDF-574.12 KB]


Details:
  • Personal Authors:
  • Keywords:
  • Pubmed ID:
    24777606
  • Pubmed Central ID:
    PMC4047155
  • Description:
    Background

    Many women with early-stage breast cancer are working at the time of diagnosis and survive without recurrence. The short-term impact of chemotherapy receipt on employment has been demonstrated, but the long-term impact merits further research.

    Methods

    We conducted a longitudinal multicenter cohort study of women diagnosed with non-metastatic breast cancer in 2005–2007, as reported to the population-based Los Angeles and Detroit SEER registries. Of 3133 individuals sent surveys, 2290 (73%) completed a baseline survey soon after diagnosis and 1536 (68%) completed a four-year follow-up questionnaire.

    Results

    Of the 1026 patients aged <65 at diagnosis whose breast cancer did not recur and who responded to both surveys, 746 (76%) worked for pay before diagnosis. Of these, 236 (30%) were no longer working at follow-up. Women who received chemotherapy as part of initial treatment were less likely to work at follow-up (38% vs. 27%, p=0.003). Chemotherapy receipt at the time of diagnosis (OR 1.4, p=0.04) was independently associated with unemployment during survivorship in a multivariable model. Many women who were not employed in the survivorship period wanted to work: 50% reported that it was important for them to work and 31% were actively seeking work.

    Conclusions

    Unemployment among breast cancer survivors four years after diagnosis is often undesired and appears related to the receipt of chemotherapy during initial treatment. These findings should be considered when patients decide whether to receive adjuvant chemotherapy, particularly when expected benefit is low.

  • Document Type:
    Journal Article
  • Collection(s):
    CDC Public Access
  • Funding:
    1U58DP00807-01/DP/NCCDPHP CDC HHS/United States
    K05 CA111340/CA/NCI NIH HHS/United States
    K05CA111340/CA/NCI NIH HHS/United States
    N01-PC-35139/PC/NCI NIH HHS/United States
    N01-PC-35145/PC/NCI NIH HHS/United States
    N01-PC-54404/PC/NCI NIH HHS/United States
    N01PC35139/CA/NCI NIH HHS/United States
    N01PC35145/CA/NCI NIH HHS/United States
    N01PC54404/CA/NCI NIH HHS/United States
    R01 CA088370/CA/NCI NIH HHS/United States
    R01 CA088370/CA/NCI NIH HHS/United States
    R01 CA109696/CA/NCI NIH HHS/United States
    R01 CA109696/CA/NCI NIH HHS/United States
No Related Documents.
You May Also Like:
  1. Managing cancer and employment: Decisions and strategies used by breast cancer survivors employed in low-wage jobs
    Personal Author:
    Swanberg, Jennifer E.; Nichols, Helen M.; Ko, Jungyai; Tracy, J. Kathleen; Vanderpool, Robin C.;
    Published:
    2017 Mar-Apr
    Source:
    J Psychosoc Oncol. 35(2):180-201.
    Description:
    Advances in breast cancer screening and treatment have led to an overall 5-year survival rate of 90%. Many of these cancer cases are diagnosed in working women. Few studies have explicitly examined the cancer-work interface, as experienced by low-wag...
    File Type:
    Filetype[PDF - 123.06 KB]
  2. The Economics of Breast Cancer in Younger Women in the U.S
    Personal Author:
    Ekwueme, Donatus U.; Trogdon, Justin G.;
    Published:
    Feb 2016
    Source:
    Am J Prev Med. 50(2):249-254.
    File Type:
    Filetype[PDF - 173.18 KB]
  3. American Cancer Society Colorectal Cancer Survivorship Care Guidelines
    Personal Author:
    El-Shami, Khaled; Oeffinger, Kevin C.; Erb, Nicole L.; Willis, Anne; Bretsch, Jennifer; Pratt-Chapman, Mandi L.; Cannady, Rachel; Wong, Sandra L.; Rose, Johnie; Barbour, April; Stein, Kevin; Sharpe, Katherine; Brooks, Durado D.; Cowens-Alvarado, Rebecca L.;
    Published:
    2015 Nov-Dec
    Source:
    CA Cancer J Clin. 65(6):428-455.
    Description:
    Colorectal cancer (CRC) is the third most common cancer and third leading cause of cancer death in both men and women and second leading cause of cancer death when men and women are combined in the United States (US). Almost two-thirds of CRC survivo...
    File Type:
    Filetype[PDF - 2.48 MB]
  4. Do Cancer-Related Fatigue and Physical Activity Vary by Age for Black Women With a History of Breast Cancer?
    Personal Author:
    Swen, Melody; Mann, Amandeep; Paxton, Raheem J.; Dean, Lorraine T.;
    Published:
    Nov 30 2017
    Source:
    Prev Chronic Dis. 14.
    Description:
    Introduction : Cancer-related fatigue (CRF) is the most uncomfortable symptom among women with a history of breast cancer. Black women are more likely than women of other racial/ethnic groups to have CRF risk factors, such as physical inactivity and ...
    File Type:
    Filetype[PDF - 327.24 KB]
  5. Coming Soon
    Treatment-Associated Toxicities Reported by Patients with Early-Stage Invasive Breast Cancer
    Personal Author:
    Friese, Christopher R.; Harrison, Jordan M.; Janz, Nancy K.; Jagsi, Reshma; Morrow, Monica; Li, Yun; Hamilton, Ann S.; Ward, Kevin C.; Kurian, Allison W.; Katz, Steven J.; Hofer, Timothy P.;
    Published:
    Jan 24 2017
    Source:
    Cancer. 123(11):1925-1934.
    Description:
    Background : Patient-reported toxicities help to appraise the breast cancer treatment experience. Yet extant data come from clinical trials and healthcare claims, which may be biased. Using patient surveys, we sought to quantify the frequency, severi...
    Public Access
    Available on:
    June 01, 2018